Callan Family Office LLC Makes New Investment in Humana Inc. $HUM

Callan Family Office LLC bought a new position in shares of Humana Inc. (NYSE:HUM) in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 1,355 shares of the insurance provider’s stock, valued at approximately $538,000.

Several other institutional investors and hedge funds have also modified their holdings of the business. Revolve Wealth Partners LLC acquired a new position in shares of Humana during the 4th quarter worth approximately $202,000. Woodline Partners LP grew its holdings in shares of Humana by 460.0% during the 1st quarter. Woodline Partners LP now owns 10,192 shares of the insurance provider’s stock worth $2,697,000 after purchasing an additional 8,372 shares in the last quarter. Sivia Capital Partners LLC grew its holdings in shares of Humana by 53.7% during the 2nd quarter. Sivia Capital Partners LLC now owns 1,293 shares of the insurance provider’s stock worth $316,000 after purchasing an additional 452 shares in the last quarter. Cresset Asset Management LLC increased its position in shares of Humana by 10.3% in the second quarter. Cresset Asset Management LLC now owns 2,369 shares of the insurance provider’s stock worth $581,000 after purchasing an additional 222 shares during the period. Finally, WINTON GROUP Ltd increased its position in shares of Humana by 58.5% in the second quarter. WINTON GROUP Ltd now owns 2,381 shares of the insurance provider’s stock worth $582,000 after purchasing an additional 879 shares during the period. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on HUM shares. The Goldman Sachs Group increased their price objective on shares of Humana from $158.00 to $195.00 and gave the stock a “sell” rating in a research note on Thursday, April 30th. Truist Financial boosted their price objective on shares of Humana from $320.00 to $415.00 and gave the company a “hold” rating in a research report on Tuesday, July 14th. HSBC cut Humana to a “hold” rating in a research note on Thursday, July 30th. Oppenheimer reaffirmed an “outperform” rating and issued a $405.00 target price on shares of Humana in a report on Thursday, July 30th. Finally, William Blair started coverage on Humana in a research note on Wednesday, May 20th. They issued an “outperform” rating on the stock. Fourteen investment analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, Humana presently has a consensus rating of “Hold” and an average price target of $403.91.

Humana Trading Up 0.6%

Shares of HUM stock opened at $388.92 on Wednesday. The firm has a market capitalization of $46.70 billion, a P/E ratio of 36.79, a P/E/G ratio of 2.20 and a beta of 0.72. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.62. The stock’s fifty day simple moving average is $383.88 and its 200 day simple moving average is $285.00. Humana Inc. has a twelve month low of $163.11 and a twelve month high of $428.88.

Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.27 by $0.34. The company had revenue of $40.89 billion during the quarter, compared to the consensus estimate of $40.58 billion. Humana had a return on equity of 11.20% and a net margin of 0.88%.The firm’s revenue was up 26.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $6.27 earnings per share. As a group, sell-side analysts predict that Humana Inc. will post 9.12 EPS for the current fiscal year.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.